What is the recommended dose of vasopressin (Vasopressin) in patients with septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Vasopressin in Septic Shock

The recommended dose of vasopressin in septic shock is 0.01-0.03 units/minute, with 0.03 units/minute being the standard target dose for most patients. 1, 2

Initial Dosing and Titration

  • According to the FDA drug label, the recommended starting dose for vasopressin in septic shock is 0.01 units/minute 2
  • Titrate up by 0.005 units/minute at 10-15 minute intervals until target blood pressure is reached 2
  • The Surviving Sepsis Campaign guidelines recommend vasopressin 0.03 units/minute as an adjunct to norepinephrine with the intent of either raising MAP or decreasing norepinephrine dosage 3
  • Vasopressin is typically added when norepinephrine requirements are moderate to high and should be considered as an adjunctive agent rather than a first-line vasopressor 1

Maximum Dosing

  • Doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy (failure to achieve adequate MAP with other vasopressor agents) 3
  • There are limited data for doses above 0.07 units/minute for septic shock, and adverse reactions are expected to increase with higher doses 2
  • A 2022 study comparing 0.03 units/minute versus 0.04 units/minute found no significant difference in hemodynamic response between these two dosages, suggesting no additional benefit from the higher dose 4

Clinical Application

  1. First-line therapy: Begin with norepinephrine (0.05-0.1 μg/kg/min) as the first-choice vasopressor 1
  2. When to add vasopressin: Consider adding vasopressin when:
    • Target MAP (≥65 mmHg) is not achieved despite adequate fluid resuscitation
    • Norepinephrine requirements are increasing
  3. Vasopressin dosing:
    • Start at 0.01 units/minute 2
    • Titrate by 0.005 units/minute every 10-15 minutes 2
    • Target dose of 0.03 units/minute 3, 1

Monitoring and Safety

  • All patients requiring vasopressors should have an arterial catheter placed as soon as practical for continuous blood pressure monitoring 3, 1
  • After target blood pressure has been maintained for 8 hours without catecholamines, taper vasopressin by 0.005 units/minute every hour as tolerated 2
  • Monitor for potential adverse effects including digital ischemia, mesenteric ischemia, and myocardial ischemia 5
  • Vasopressin response (defined as a lowering of catecholamine dose required to maintain MAP ≥65 mmHg) at 6 hours after initiation is associated with more favorable clinical outcomes 6

Important Considerations

  • Ensure adequate fluid resuscitation before or during vasopressor therapy 1
  • Vasopressin infusions of >0.04 units/minute may lead to adverse vasoconstriction-mediated events 7
  • Vasopressin should be diluted in normal saline (0.9% sodium chloride) or 5% dextrose in water prior to intravenous administration 2
  • Discard unused diluted solution after 18 hours at room temperature or 24 hours under refrigeration 2

By following these evidence-based recommendations for vasopressin dosing in septic shock, clinicians can optimize hemodynamic support while minimizing potential adverse effects.

References

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vasopressin Response and Clinical Trajectory in Septic Shock Patients.

Journal of intensive care medicine, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.